Abstract

BackgroundYemen has witnessed several dengue fever outbreaks coincident with the social unrest and war in the country. The aim of the present study was to describe the knowledge, attitudes and practices (KAPs) of at-risk urban populations residing in Taiz, southwest of Yemen. In addition, factors possibly associated with poor preventive practices were investigated.MethodsA household-based, cross-sectional survey was conducted in three urban districts encompassing 383 households. Data on the socio-demographic characteristics and KAPs of the participating household heads were collected using a pre-designed, structured questionnaire. The association of socio-demographic characteristics, knowledge and attitudes of the population with poor preventive practices against dengue fever was then analyzed using logistic regression.ResultsMore than 90.0 % of respondent household heads had correct knowledge about fever, headache and joint pain as common signs and symptoms of dengue fever. Moreover, muscular pain and bleeding were perceived by more than 80.0 % of the respondents as being associated with dengue fever; however, only 65.0 % of the respondents reported skin rash as a sign of dengue fever. More than 95.0 % of respondents agreed about the seriousness and possible transmission of dengue fever; however, negative attitudes regarding the facts of being at risk of the disease and that the infection is preventable were expressed by 15.0 % of respondents. Despite the good level of knowledge and attitudes of the respondent population, poor preventive practices were common. Bivariate analysis identified poor knowledge of dengue signs and symptoms (OR = 2.1, 95 % CI = 1.24–3.68; P = 0.005) and its vector (OR = 2.1, 95 % CI = 1.14–3.84; P = 0.016) as factors significantly associated with poor preventive practices. However, multivariable analysis showed that poor knowledge of the vector is an independent predictor of poor preventive practices of the population (adjusted OR = 2.1, 95 % CI = 1.14–3.84; P = 0.018).ConclusionThe majority of people in urban communities of Taiz have a clear understanding of most signs/symptoms of dengue fever as well as positive attitudes towards the seriousness and possible transmissibility of dengue fever. However, negative attitudes regarding their perception of the risk and possible prevention of the infection are prevailing among a small proportion of the population and need to be targeted by educational campaigns. It appears that the good level of the population knowledge of the signs/symptoms of dengue fever and the factors contributing to the spread and control of its vectors did not translate into good practices.

Highlights

  • Yemen has witnessed several dengue fever outbreaks coincident with the social unrest and war in the country

  • The majority of people in urban communities of Taiz have a clear understanding of most signs/ symptoms of dengue fever as well as positive attitudes towards the seriousness and possible transmissibility of dengue fever. Negative attitudes regarding their perception of the risk and possible prevention of the infection are prevailing among a small proportion of the population and need to be targeted by educational campaigns. It appears that the good level of the population knowledge of the signs/symptoms of dengue fever and the factors contributing to the spread and control of its vectors did not translate into good practices

  • With the increasing incidence of dengue outbreaks in Yemen, the present study describes the KAPs of at-risk populations pertaining to dengue fever in three urban districts of Taiz

Read more

Summary

Introduction

Yemen has witnessed several dengue fever outbreaks coincident with the social unrest and war in the country. Infection with dengue virus may be asymptomatic [7, 8], it may lead to a wide spectrum disease that ranges from non-severe fever to potentially fatal clinical manifestations [1]. It is noteworthy that the recombinant live-attenuated tetravalent dengue vaccine (CYD-TDV), commercially known as Dengvaxia®, was the first licensed vaccine against dengue, given as three doses at 0, 6 and 12 months [13]; its pooled efficacy over 25 months from the first dose was reported to be 65.6 % based on data derived from Phase 3 clinical trials from endemic countries in Asia and Latin America, with varying degrees of protection according to the virus serotype, age, disease severity and serostatus at vaccination [14]. The Strategic Advisory Group of Experts on Immunization recommends the introduction of CYD-TDV only in highendemicity settings, after careful assessment, where seroprevalence rates of the virus are 70 % or greater in the age group to be targeted by vaccination [15]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call